Systems aren’t truly random—outcomes are shaped by structure, constraints, and time, just like reliability performance in industrial operations. Early system states are constrained; risk and outcome ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

As darkness retreats and flotation tanks gain popularity, a UCSD professor examines how “sensory deprivation” experiments ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

The platformer had multiplayer, but its Switch 2 upgrade turns it into a full-on party game with tons of minigames to explore.

When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t ...

A brief, calorie-restricted diet centered almost entirely on oats led to a surprisingly strong and lasting reduction in cholesterol in people with metabolic syndrome. A very short dietary intervention ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Breaking new science reveals how a specific fiber can decrease liver fat synthesis, increase fat burning, and even turn sugar into proteins. But that's only the ...

The trial is an interventional Phase 2 study with patients randomly assigned to either elezanumab or placebo in parallel groups. It is double-blind with masking of patients, doctors, and assessors, ...

Immigration has become one of America’s sharpest flashpoints, increasingly framed not only as a border issue but as a public ...